Jeff Michaels, OD, MBA, FAAO: CSI Dry Eye Software: Speaker's Bureau (honoraria or other compensation) (); Lumenis: Speaker's Bureau (honoraria or other compensation) ()
Interventional dry eye treatments are now driven by in-office devices to aid the optometrists diagnosis and treatment. We will review in-office technologies and explore why some financial outlays become your boat anchor (and not used) versus effective treatments that patients come back asking for more.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Review DEWS III principles
Gain knowledge of devices options for treating ocular surface disease and meibomian gland dysfunction
Learn indications and contraindications for each interventional treatment
Learn how to incorporate new device technology into patient work flows.
